(XERS) Xeris Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xeris Pharmaceuticals | (XERS) share price targets
Complete technical analysis of Xeris Pharmaceuticals (XERS) by charts plus indicators, forecast predictions and share price targets for Xeris Pharmaceuticals (XERS)
Xeris Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Xeris Pharmaceuticals is 1263000
| Date | Daily Closing Price | Open | High | Low | Volume |
| 10 Tue Feb 2026 | 7.22 | 7.00 | 7.22 | 6.90 | 0.655 times |
| 09 Mon Feb 2026 | 6.96 | 7.00 | 7.06 | 6.86 | 0.827 times |
| 06 Fri Feb 2026 | 7.01 | 7.00 | 7.10 | 6.93 | 0.778 times |
| 05 Thu Feb 2026 | 6.91 | 7.01 | 7.20 | 6.84 | 1.075 times |
| 04 Wed Feb 2026 | 7.08 | 7.40 | 7.42 | 6.97 | 1.235 times |
| 03 Tue Feb 2026 | 7.34 | 7.37 | 7.56 | 7.26 | 1.053 times |
| 02 Mon Feb 2026 | 7.35 | 7.33 | 7.59 | 7.23 | 0.839 times |
| 30 Fri Jan 2026 | 7.36 | 7.30 | 7.45 | 7.22 | 1.181 times |
| 29 Thu Jan 2026 | 7.24 | 7.15 | 7.33 | 7.05 | 1.044 times |
| 28 Wed Jan 2026 | 7.14 | 7.49 | 7.52 | 7.14 | 0.946 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 7.1 as stoploss in an intra day buy trade for a target of 7.36. However, stock will show a bearish move below 7.1.
Share price targets for Xeris Pharmaceuticals (XERS)
| Target Type | Value |
| Downside Target | 6.47 |
| Downside Target | 6.71 |
| Downside Target | 7.05 |
| Downside Target | 7.22 |
| Upside Target | 7.59 |
| Upside Target | 7.78 |
| Upside Target | 7.85 |
| Upside Target | 7.97 |
| Upside Target | 8.22 |
| Upside Target | 8.42 |
| Upside Target | 10.03 |
| Upside Target | 10.08 |
Intraday share price targets for Xeris Pharmaceuticals (XERS)
| Target Type | Value |
| Downside Intraday Target | 6.98 |
| Downside Intraday Target | 6.74 |
| Upside Intraday Target | 7.34 |
| Upside Intraday Target | 7.46 |
| Downside Intraday Target | 7.1 |
Weekly technical analysis of Xeris Pharmaceuticals (XERS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 10 Tue Feb 2026 | 7.22 | 7.00 | 7.22 | 6.86 | 0.297 times |
| 06 Fri Feb 2026 | 7.01 | 7.33 | 7.59 | 6.84 | 0.984 times |
| 30 Fri Jan 2026 | 7.36 | 7.42 | 7.65 | 7.05 | 0.995 times |
| 23 Fri Jan 2026 | 7.44 | 7.39 | 7.85 | 7.25 | 0.756 times |
| 16 Fri Jan 2026 | 7.52 | 7.87 | 7.97 | 7.36 | 0.487 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Xeris Pharmaceuticals (XERS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 10 Tue Feb 2026 | 7.22 | 7.33 | 7.59 | 6.84 | 0.196 times |
| 30 Fri Jan 2026 | 7.36 | 7.88 | 8.42 | 6.88 | 0.964 times |
| 31 Wed Dec 2025 | 7.85 | 7.08 | 8.22 | 6.47 | 0.845 times |
| 28 Fri Nov 2025 | 7.18 | 9.54 | 10.08 | 6.71 | 1.005 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Xeris Pharmaceuticals (XERS)
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Xeris Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Xeris Pharmaceuticals in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Xeris Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Xeris Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Xeris Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.16 and Xeris Pharmaceuticals (XERS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Xeris Pharmaceuticals (XERS) stock. Volume based technical analysis of Xeris Pharmaceuticals (XERS) stock is negative.
Xeris Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Xeris Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Xeris Pharmaceuticals in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Xeris Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Xeris Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Xeris Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.16 and Xeris Pharmaceuticals (XERS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Xeris Pharmaceuticals (XERS) stock. Volume based technical analysis of Xeris Pharmaceuticals (XERS) stock is negative.
Xeris Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.